NO20052280L - Substituerte tetraliner og indaner og deres anvendelse - Google Patents

Substituerte tetraliner og indaner og deres anvendelse

Info

Publication number
NO20052280L
NO20052280L NO20052280A NO20052280A NO20052280L NO 20052280 L NO20052280 L NO 20052280L NO 20052280 A NO20052280 A NO 20052280A NO 20052280 A NO20052280 A NO 20052280A NO 20052280 L NO20052280 L NO 20052280L
Authority
NO
Norway
Prior art keywords
indanes
substituted tetralines
tetralines
substituted
tetralin
Prior art date
Application number
NO20052280A
Other languages
English (en)
Other versions
NO332352B1 (no
Inventor
Keith Demarest
Jay M Matthews
Xiaoli Chen
Jung Lee
Philip Rybczynski
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20052280L publication Critical patent/NO20052280L/no
Publication of NO332352B1 publication Critical patent/NO332352B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

Foreliggende oppfinnelse angår tetralin- og indanforbindelser, sammensetninger som inneholder dem, og fremgangsmåte for anvendelse av dem som PPAR alfa modulatorer for behandling eller inhibering av progresjon av for eksempel diabetes.
NO20052280A 2002-10-21 2005-05-10 Substituerte tetraliner og indaner og deres anvendelse samt en farmasoytisk sammensetning NO332352B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42002602P 2002-10-21 2002-10-21
US49578803P 2003-08-15 2003-08-15
PCT/US2003/033371 WO2004037779A1 (en) 2002-10-21 2003-10-17 Substituted tetralins and indanes and their use

Publications (2)

Publication Number Publication Date
NO20052280L true NO20052280L (no) 2005-06-24
NO332352B1 NO332352B1 (no) 2012-09-03

Family

ID=32179777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052280A NO332352B1 (no) 2002-10-21 2005-05-10 Substituerte tetraliner og indaner og deres anvendelse samt en farmasoytisk sammensetning

Country Status (28)

Country Link
US (2) US20040167211A1 (no)
EP (1) EP1554240B1 (no)
JP (1) JP4411275B2 (no)
KR (1) KR100989394B1 (no)
CN (1) CN100354259C (no)
AT (1) ATE430728T1 (no)
AU (1) AU2003279996B2 (no)
BR (1) BR0315623A (no)
CA (1) CA2502665A1 (no)
CY (1) CY1110326T1 (no)
DE (1) DE60327543D1 (no)
DK (1) DK1554240T3 (no)
EA (1) EA009554B1 (no)
ES (1) ES2325783T3 (no)
HR (1) HRP20050336B1 (no)
IL (1) IL168147A (no)
ME (1) MEP53108A (no)
MX (1) MXPA05004192A (no)
NO (1) NO332352B1 (no)
NZ (1) NZ539451A (no)
PL (1) PL376326A1 (no)
PT (1) PT1554240E (no)
RS (1) RS52079B (no)
SI (1) SI1554240T1 (no)
TW (1) TWI308563B (no)
UA (1) UA80561C2 (no)
WO (1) WO2004037779A1 (no)
ZA (1) ZA200504064B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094786A1 (en) * 2002-10-21 2006-05-04 Xiaoli Chen Treating syndrome X with substituted tetralins and indanes
KR20050067419A (ko) * 2002-10-21 2005-07-01 얀센 파마슈티카 엔.브이. 치환된 테트라린 및 인단으로의 ｘ 증후군의 치료
RS20050318A (sr) * 2002-10-21 2007-09-21 Janssen Pharmaceutica N.V., Supstituisani tetralini i indani
US20060247314A1 (en) * 2002-10-21 2006-11-02 Xiaoli Chen Substituted tetralins and indanes
AR048931A1 (es) 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis
JP4619413B2 (ja) * 2004-10-12 2011-01-26 ファーマコペイア ドラッグ ディスカバリー， インコーポレイテッド 肥満および関連障害の処置のための選択的メラニン濃縮ホルモンレセプターアンタゴニストとしての二環式化合物
KR101804650B1 (ko) * 2013-03-20 2018-01-10 에프. 호프만-라 로슈 아게 우레아 유도체 및 이의 지방산 결합 단백질(fabp) 억제제로서의 용도

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU632809B2 (en) * 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
GB9027023D0 (en) 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
WO1995004713A1 (en) 1993-08-06 1995-02-16 The Upjohn Company 2-aminoindans as selective dopamine d3 ligands
GB9606805D0 (en) 1996-03-30 1996-06-05 Glaxo Wellcome Inc Medicaments
EP1666587A1 (en) 1996-06-13 2006-06-07 Astellas Pharma Inc. Cyclic lipopeptide acylase
GB9822473D0 (en) * 1998-10-16 1998-12-09 Glaxo Group Ltd Chemical compounds
US6300339B1 (en) * 1998-10-21 2001-10-09 Novo Nordisk A/S Compounds, their preparation and use
TWI234557B (en) 1999-05-26 2005-06-21 Telik Inc Novel naphthalene ureas as glucose uptake enhancers
EP1259494A4 (en) * 2000-02-18 2004-09-15 Merck & Co Inc ARYLOXYACETIC ACIDS FOR DIABETES AND LIPID DISORDERS
SK4132003A3 (en) * 2000-10-05 2004-02-03 Bayer Ag Propionic acid derivatives, the process for their preparation, pharmaceutical composition comprising them, use thereof and intermediates for producing them
JPWO2002044129A1 (ja) * 2000-11-29 2004-04-02 杏林製薬株式会社 置換カルボン酸誘導体
AU2002222573A1 (en) * 2000-12-05 2002-06-18 Kyorin Pharmaceutical Co. Ltd. Substituted carboxylic acid derivatives
WO2002050047A1 (en) * 2000-12-20 2002-06-27 Glaxo Group Limited Substitued oxazoles and thiazoles as hppar alpha agonists
TWI241190B (en) 2001-02-13 2005-10-11 Aventis Pharma Gmbh 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
EP1360172A1 (en) 2001-02-15 2003-11-12 Pfizer Products Inc. Ppar agonists
CA2438492A1 (en) 2001-02-15 2002-08-22 Pfizer Products Inc. Proliferative activator receptor (ppar) compounds
US6548538B2 (en) * 2001-05-22 2003-04-15 Bayer Aktiengesellschaft Propionic acid derivatives
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
RS20050318A (sr) * 2002-10-21 2007-09-21 Janssen Pharmaceutica N.V., Supstituisani tetralini i indani
KR20050067419A (ko) * 2002-10-21 2005-07-01 얀센 파마슈티카 엔.브이. 치환된 테트라린 및 인단으로의 ｘ 증후군의 치료
US20060247314A1 (en) * 2002-10-21 2006-11-02 Xiaoli Chen Substituted tetralins and indanes
US20060094786A1 (en) * 2002-10-21 2006-05-04 Xiaoli Chen Treating syndrome X with substituted tetralins and indanes
AR048931A1 (es) * 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis

Also Published As

Publication number Publication date
EA009554B1 (ru) 2008-02-28
PT1554240E (pt) 2009-06-17
JP4411275B2 (ja) 2010-02-10
JP2006503917A (ja) 2006-02-02
AU2003279996A1 (en) 2004-05-13
CN100354259C (zh) 2007-12-12
ES2325783T3 (es) 2009-09-17
BR0315623A (pt) 2005-08-23
RS20050320A (sr) 2007-11-15
DK1554240T3 (da) 2009-08-17
US7351857B2 (en) 2008-04-01
US20040167211A1 (en) 2004-08-26
UA80561C2 (en) 2007-10-10
US20060074130A1 (en) 2006-04-06
CN1726187A (zh) 2006-01-25
EP1554240A1 (en) 2005-07-20
TW200418774A (en) 2004-10-01
RS52079B (sr) 2012-06-30
ZA200504064B (en) 2006-09-27
MEP53108A (en) 2011-05-10
PL376326A1 (en) 2005-12-27
SI1554240T1 (sl) 2009-10-31
TWI308563B (en) 2009-04-11
ATE430728T1 (de) 2009-05-15
IL168147A (en) 2010-11-30
CA2502665A1 (en) 2004-05-06
KR20050071597A (ko) 2005-07-07
HRP20050336B1 (hr) 2013-06-30
EA200500516A1 (ru) 2005-10-27
EP1554240B1 (en) 2009-05-06
DE60327543D1 (de) 2009-06-18
AU2003279996B2 (en) 2009-07-09
CY1110326T1 (el) 2015-01-14
NZ539451A (en) 2008-03-28
WO2004037779A1 (en) 2004-05-06
HRP20050336A2 (en) 2006-11-30
NO332352B1 (no) 2012-09-03
KR100989394B1 (ko) 2010-10-25
MXPA05004192A (es) 2005-09-20

Similar Documents

Publication Publication Date Title
CY1110555T1 (el) 4-((φαινοξυαλκυλ)θειο)-φαινοξυοξεικα οξεα και αναλογα
TW200519089A (en) Biaryl sulfonamides and methods for using same
CY1110326T1 (el) Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους
TW200519100A (en) Biaryl sulfonamides and methods for using same
MXPA05004384A (es) Piperacinil y diacepanil benzamidas y benztioamidas.
DE602005017753D1 (de) Mittel für die transdermale verabreichung von nikotin
CR8377A (es) Derivados de acidos fenoxiaceticos utiles como agonistas dobles de receptor activado por proliferador de peroxisoma
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
NO20060242L (no) Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin
DE60329326D1 (de) Tace inhibitoren
NO20052277L (no) Behandling av syndrom X med substituerte tetraliner og indaner
DE60327936D1 (de) Modulatoren von ship-1
UA93358C2 (en) 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
SG149041A1 (en) 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
MXPA05004191A (es) Tetralinas e indanos sustituidos.
MY145712A (en) 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
ECSP066623A (es) Bencimidazol-, benztriazol-, y bencimidazolona-o-glucosidos sustituidos
TW200504016A (en) Inhibitors of monoamine uptake
EA200600183A1 (ru) Сочетание ингибитора обратного захвата серотонина и агомелатина

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees